IQVIA Reports Q4 2025 Earnings: Revenue Beats Estimates, EPS Near Consensus, Guidance Below Expectations

IQV
February 05, 2026

IQVIA released its fourth‑quarter 2025 earnings before the market opened on February 5, 2026, reporting a revenue of $4.36 billion and an adjusted earnings per share of $3.42.

Revenue rose 10.3% year‑over‑year to $4.36 billion, beating the consensus estimate of $4.24 billion by roughly 1.9% to 2.9%. The growth was driven by strong performance in the newly renamed Commercial Solutions segment, which absorbed the former Contract Sales & Medical Solutions unit, and by continued expansion in Research & Development Solutions, both of which reported higher bookings than the same quarter a year earlier.

Adjusted EPS of $3.42 came in slightly ahead of the $3.40 consensus estimate, a $0.02 or 0.5% beat. The result reflects disciplined cost management and a favorable mix shift toward higher‑margin AI‑enabled services, offsetting modest pricing pressure in legacy data‑services contracts.

The company’s restructuring, effective January 1, 2026, merged Contract Sales & Medical Solutions into Commercial Solutions and moved certain real‑world offerings into Research & Development Solutions. This realignment sharpened the focus on high‑growth, high‑margin segments and helped explain the revenue lift and margin profile for the quarter.

CEO Ari Bousbib highlighted the quarter as the strongest for the company, noting that “IQVIA closed 2025 with strong performance across all segments. We delivered near double‑digit revenue and EPS growth, and the strongest quarter of the year in R&D net bookings.” He added that an expanded go‑to‑market strategy, operational discipline, and AI investments drove the topline momentum and positioned the firm for 2026.

For the full year 2026, IQVIA guided revenue to $17.15 billion–$17.35 billion, adjusted EBITDA to $3.975 billion–$4.025 billion, and adjusted diluted EPS to $12.55–$12.85. The EPS guidance sits below the consensus estimate of $12.96, a shortfall that has tempered investor sentiment despite the quarter’s revenue beat.

The earnings beat and near‑in‑line EPS underscore IQVIA’s execution strength, but the lower 2026 guidance signals management’s caution about macro‑economic headwinds and competitive pressure. The company’s focus on AI and a restructured segment mix suggests a strategic pivot toward higher‑margin, scalable services, while the guidance gap highlights the need for continued cost discipline and revenue growth to meet market expectations.

The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.